Rifampicin$RIF Price Today
Rifampicin ($RIF) Price Overview
As of now Rifampicin $RIF is trading at $0.002031, reflecting a 6.26% increase over the past 24 hours.
The 24-hour trading volume for $RIF is $95.2K, an increase of 6.26% from yesterday.
Its current market capitalization is approximately $2.0M. Liquidity across major Solana DEXes is currently at $731.7K.
$RIF is actively traded in Solflare wallet. The token is verified according to Solana's token registry. This token can be swapped instantly on Solflare for any other supported asset. You can also set advanced limit orders for this token directly within the Solflare wallet, allowing you to automate trades based on your chosen price targets.
Rifampicin ($RIF) is a Solana-based token that is also regarded as an altcoin in the broader cryptocurrency market. Whether used as a stable asset or a tradable cryptocurrency, this altcoin benefits from Solana's high-performance blockchain, giving traders and investors access to fast transactions and low fees.
Market Data
Market Cap
Volume 24h
FDV
Liquidity
Max Supply
Circulating Supply
About Rifampicin $RIF
$RIF token represents longevity experiments performed with the compound Rifampicin. These experiments are live-streamed on Pump Science. What is Pump Science? Pump Science is a gamified longevity research platform. Users can speculate on life-extending compounds, stream live experiment data, and submit your own longevity cocktails for testing on model organisms. What is Rifampicin? Rifampicin is traditionally known as an antibiotic, but it’s been gaining attention for its surprising effects on aging. In tiny organisms like C. elegans (a model organism often used in aging research), Rifampicin has been shown to activate the cell’s natural defense mechanisms against stress and damage. Imagine it as a sort of "cellular coach," encouraging cells to stay healthy and resilient by protecting against harmful oxidative stress and maintaining the quality of proteins within the cell. These protective effects help the worms live longer and healthier lives. While it’s still early days, and we don’t yet know if Rifampicin can do the same in humans, its ability to promote cellular health makes it an exciting area of research in the quest for anti-aging therapies.